Reliance Develops R-Green kit- can give COVID results in 2 hours
Reliance Life Sciences has developed an real-time reverse transcription-polymerase chain reaction (RT-PCR) kit. It claims to diagnose COVID-19 infection in about 2 hours. Presently, COVID-19 RT-PCR test takes up to 24 hours to give a diagnosis.
Key Facts
- The kit has been developed by Computational biologists at Reliance Life Sciences a subsidiary of Reliance Industries Ltd.
- This kit is indigenous development of the R&D scientists working at the firm.
- They analysed more than 100 genomes of SARS-CoV-2 sequenced in India in order to design RT-PCR primers for developing quantitative-Real Time PCR kit.
- The kit has been technically validated by ICMR for satisfactory performance. It does not approve or disapprove the kit design as well as it does not certify user-friendliness.
R-Green Kit
The kit can detect the presence of E-gene, R-gene, RdRp gene of SARS COV2 virus with Actin as an internal control. According to the ICMR results, the kit is 98.7 % sensitive and 98.8 % specific. The diagnosis time of the kit is approximately 2 hours.
Study by Reliance Life Sciences
- The study says, the death rate for COVID-19 pandemic may significantly reduce by the end of 2020.
- As per them, mutation occurrence of structural and non-structural proteins of SARS-CoV-2 form more than 7,000 genome sequences of SARS-CoV-2 virus from 49 countries.
- There is an inverse correlation between the mutation rates of two proteins NSP6 and Surface glycoprotein (S) with the death rate.
- They predicted that mutations of these two proteins will grow constantly and the death rate would drop below 0.5% by end of 2020 in cluster I countries.
- They said, mutation rate of NSP6 and S proteins are lower than cluster I and cluster III countries.
- Therefore, in cluster II country the death rate of COVID-19 pandemic will weaken later than cluster I and III countries.
- Note:
- Cluster I countries – India and Bangladesh
- Cluster II country – USA
- Cluster III countries- Australia and New Zealand.